ES8703023A1 - Un metodo para diagnostico in vitro a fin de detectar la presencia en un paciente de celulas de cancer u otras celulas que produzcan antigenos muninoros. - Google Patents

Un metodo para diagnostico in vitro a fin de detectar la presencia en un paciente de celulas de cancer u otras celulas que produzcan antigenos muninoros.

Info

Publication number
ES8703023A1
ES8703023A1 ES85544483A ES544483A ES8703023A1 ES 8703023 A1 ES8703023 A1 ES 8703023A1 ES 85544483 A ES85544483 A ES 85544483A ES 544483 A ES544483 A ES 544483A ES 8703023 A1 ES8703023 A1 ES 8703023A1
Authority
ES
Spain
Prior art keywords
vitro
blood
antigene
mucinous
fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES85544483A
Other languages
English (en)
Spanish (es)
Other versions
ES544483A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mucan Diagnostics Pty Ltd
Original Assignee
Mucan Diagnostics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mucan Diagnostics Pty Ltd filed Critical Mucan Diagnostics Pty Ltd
Publication of ES544483A0 publication Critical patent/ES544483A0/es
Publication of ES8703023A1 publication Critical patent/ES8703023A1/es
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5753—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the stomach or small intestine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Investigating Or Analyzing Materials By The Use Of Fluid Adsorption Or Reactions (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
ES85544483A 1984-06-25 1985-06-24 Un metodo para diagnostico in vitro a fin de detectar la presencia en un paciente de celulas de cancer u otras celulas que produzcan antigenos muninoros. Expired ES8703023A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPG567284 1984-06-25

Publications (2)

Publication Number Publication Date
ES544483A0 ES544483A0 (es) 1987-01-16
ES8703023A1 true ES8703023A1 (es) 1987-01-16

Family

ID=3770652

Family Applications (1)

Application Number Title Priority Date Filing Date
ES85544483A Expired ES8703023A1 (es) 1984-06-25 1985-06-24 Un metodo para diagnostico in vitro a fin de detectar la presencia en un paciente de celulas de cancer u otras celulas que produzcan antigenos muninoros.

Country Status (15)

Country Link
US (2) US4818682A (enExample)
EP (1) EP0190159B1 (enExample)
JP (1) JP2520107B2 (enExample)
KR (1) KR920010296B1 (enExample)
CN (1) CN1034976C (enExample)
AT (1) ATE80470T1 (enExample)
AU (1) AU596075B2 (enExample)
CA (1) CA1263598A (enExample)
DK (1) DK170005B1 (enExample)
ES (1) ES8703023A1 (enExample)
GR (1) GR851540B (enExample)
NZ (1) NZ212419A (enExample)
PH (1) PH23387A (enExample)
WO (1) WO1986000414A1 (enExample)
ZA (1) ZA854700B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5160723A (en) * 1985-04-19 1992-11-03 Sloan-Kettering Institute For Cancer Research Method of imaging colorectal carcinoma lesion and composition for use therein
ES8800604A1 (es) * 1985-04-22 1987-11-16 Hybritech Inc Un metodo para producir anticuerpos monoclonales
US5552291A (en) * 1985-10-09 1996-09-03 Kyowa, Hakko Kogyo Co., Ltd. Anti-human pulmonary adenocarcinoma specific monoclonal antibody
JPH0673470B2 (ja) * 1986-07-15 1994-09-21 協和醗酵工業株式会社 抗ヒト胃癌単クロ−ン性抗体ａｍｃ−４６２
JP2519038B2 (ja) * 1986-07-29 1996-07-31 郁男 山科 単クロ―ン抗体及びその製造方法
NZ222509A (en) * 1986-11-19 1993-03-26 Oncogen Hybridoma cell line producing antibodies binding to tumour-associated mucin antigen
US6004761A (en) * 1986-11-19 1999-12-21 Sanofi Method for detecting cancer using monoclonal antibodies to new mucin epitopes
JP2688824B2 (ja) * 1987-05-29 1997-12-10 郁男 山科 単クローン抗体ｎｋｙ１３
US5073493A (en) * 1987-05-29 1991-12-17 Ikuo Yamashina Monoclonal antibody nky13
US5075218A (en) * 1987-12-29 1991-12-24 Biomira, Inc. Screening for antibodies which bind carbohydrate epitopes of tumor-associated antigens, and uses thereof
US4921789A (en) * 1988-04-20 1990-05-01 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same
US5292667A (en) * 1988-06-29 1994-03-08 The General Hospital Corporation Detection and treatment of ulcerative colitis
WO1990012892A1 (en) * 1989-04-14 1990-11-01 The Regents Of The University Of California Human intestinal mucin
DE69029270T2 (de) * 1989-09-15 1997-03-27 Genetic Systems Corp., Seattle, Wash. HYBRIDOMA CT43, DAS EIN ANTIKöRPER GEGEN EIN MUCINEPITOP VON DARMKREBS ERZEUGT
US5110911A (en) * 1989-11-02 1992-05-05 Biomira, Inc. Human tumor-associated thomsen-friedenreich antigen
US5242799A (en) * 1989-11-02 1993-09-07 Biomira, Inc. Lectin-antibody immunoassays for TF epitope-bearing antigens
WO1991008217A1 (en) * 1989-12-05 1991-06-13 The Regents Of The University Of California Human intestinal mucins
US5256540A (en) * 1990-12-28 1993-10-26 Mayo Foundation For Medical Education And Research Immunoassay for small cell lung carcinoma
US5245017A (en) * 1991-05-31 1993-09-14 Applied Biotechnology, Inc. Method for isolating CEA-binding protein
US5278290A (en) * 1991-05-31 1994-01-11 Applied Biotechnology, Inc. Binding protein for CEA and uses thereof
US5281697A (en) * 1991-05-31 1994-01-25 Applied Biotechnology, Inc. CEA-binding protein and uses thereof
EP0556496A3 (en) * 1992-02-21 1993-12-29 Dev Ct Biotechnology Antibodies against tumor-associated mucin glycoprotein
WO1995013831A1 (en) * 1993-11-17 1995-05-26 The Schepens Eye Research Institute, Inc. Antibody to ocular and vaginal surface epithelium
US5416025A (en) * 1993-11-29 1995-05-16 Krepinsky; Jiri J. Screening test for early detection of colorectal cancer
US5498608A (en) * 1994-01-07 1996-03-12 Salix Pharmaceuticals Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
CA2253093A1 (en) 1998-11-06 2000-05-06 Jiri J. Krepinsky Screening test for early detection of colorectal cancer
SE0004532D0 (sv) * 2000-12-07 2000-12-07 Caldwell Karin Dahlgren Use of mucin
EP1585960A2 (en) * 2002-01-14 2005-10-19 Vertex Pharmaceuticals Incorporated Mucin immobilized chromatography
ITTO20121154A1 (it) * 2012-12-27 2014-06-28 Fond Istituto Italiano Di Tecnologia Sistema di sonde per rivelare una sequenza nucleotidica bersaglio a singolo filamento

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4277437A (en) * 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
DE3485733D1 (de) * 1983-01-21 1992-06-25 Frederick James Primus Spezifische antigene der cea(karzyno-embryonales-antigen)familie, spezifische antikoerper und verfahren zu ihrer verwendung.
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies

Also Published As

Publication number Publication date
JPS61502701A (ja) 1986-11-20
DK170005B1 (da) 1995-04-24
NZ212419A (en) 1988-08-30
KR920010296B1 (ko) 1992-11-21
US5008184A (en) 1991-04-16
CN1034976C (zh) 1997-05-21
EP0190159A4 (en) 1988-08-04
ES544483A0 (es) 1987-01-16
KR860700154A (ko) 1986-03-31
JP2520107B2 (ja) 1996-07-31
CN85105430A (zh) 1987-05-13
EP0190159B1 (en) 1992-09-09
GR851540B (enExample) 1985-11-25
DK88086A (da) 1986-02-25
AU4499685A (en) 1986-01-24
EP0190159A1 (en) 1986-08-13
DK88086D0 (da) 1986-02-25
ZA854700B (en) 1986-02-26
CA1263598A (en) 1989-12-05
US4818682A (en) 1989-04-04
AU596075B2 (en) 1990-04-26
ATE80470T1 (de) 1992-09-15
WO1986000414A1 (en) 1986-01-16
PH23387A (en) 1989-07-26

Similar Documents

Publication Publication Date Title
ES8703023A1 (es) Un metodo para diagnostico in vitro a fin de detectar la presencia en un paciente de celulas de cancer u otras celulas que produzcan antigenos muninoros.
Peyrat et al. Prognostic significance of circulating p53 antibodies in patients undergoing surgery for locoregional breast cancer
Metzgar et al. Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma.
DE69929185D1 (de) Tumormarker
Hermon-Taylor et al. Immunofluorescent localisation of enterokinase in human small intestine.
NO904001D0 (no) Fremgangsmaate og anordning for amperometrisk diagnoseanalyse.
TR200000113T2 (tr) Tüberkülozu teşhis etmek için bileşikler ve bunları kullanma yöntemleri.
Molnar et al. CEA levels in fluids bathing gastrointestinal tumors
DK172686A (da) Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet
DK0454782T3 (da) Cancer-beslægtet haptaglobin (Hpr.)
NO177463C (no) STLV-III-beslektede polypeptider, diagnostiske prövesett og in vitro analysefremgangsmåte for påvisning av anti-HIV-2-antistoffer i kroppsvæskepröve
OA08331A (fr) Anticorps monoclonaux, lignées de cellules et trousses les contenant pour diagnostiquer les épithéliomas de poumons humains ne comportant pas de petites cellules;
Tsou et al. 5′-nucleotide phosphodiesterase isoenzyme and hepatic cancer in NCI-Mayo Clinic panel sera
ES8604693A1 (es) Un metodo para detectar un anticuerpo o un antigeno contenido en una muestra de fluido de origen biologico.
ATE135468T1 (de) Vorprüfung von prostatakrebs durch serum prostatischen spezifischen antigen
JPS6461665A (en) Antibody to human papilloma virus antigen and method of using said antibody
Emmrich et al. Leucocyte migration inhibition under agarose versus MEM test for detection of tumour-associated antigens
ATE107033T1 (de) Nachweis von tumorassozierten anzeigern in biologischen flüssigkeiten.
Goldberg The Hospital for Sick Children, Department of Biochemistry, Toronto, Ontario, Canada
Rightsel et al. Electroprecipitin test for hepatitis-associated antigen and antibody
EP1398378A4 (en) IN NEUROBLASTOM ISOLATED NUCLEIC ACIDS
Hameed et al. The Evaluation of tumor markers levels in pre and postmenopausal breast cancer women
DE3586628D1 (en) Immunoassay for detecting cells producing intestinal mucin antigen
Kithier et al. Pancreatic oncofetal antigen and carcinoembryonic antigen in breast and colon carcinoma
RU94027312A (ru) Способ дифференциальной диагностики фиброаденомы и рака молочной железы в гистологических срезах